Precisely identifying the biomarkers associated with carcinogenesis requires a multidisciplinary approach that includes genetic, genomic, metabolomic, immunological and computational expertise. The collaboration of experts in these fields at CCR is leading to new diagnostic tests and targeted therapeutics for cancer patients. We invite you to meet some of our principal investigators conducting research in this area.
